In the last trading session, 24.9 million Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP) shares changed hands as the company’s beta touched 1.07. With the company’s per share price at $10.00 changed hands at $4.98 or 99.20% during last session, the market valuation stood at $9.10M. TTNP’s last price was a discount, traded about -14.0% off its 52-week high of $11.40. The share price had its 52-week low at $4.24, which suggests the last value was 57.6% up since then. When we look at Titan Pharmaceuticals, Inc. (de)’s average trading volume, we note the 10-day average is 2.59 million shares, with the 3-month average coming to 23.86K.
Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP) trade information
Instantly TTNP was in green as seen at the end of in last trading. With action 78.28%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 21.21%, with the 5-day performance at 78.28% in the green. However, in the 30-day time frame, Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP) is 68.07% up. Looking at the short shares, we see there were 4524.0 shares sold at short interest cover period of 0.8 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 62.48%.
TTNP Dividends
Titan Pharmaceuticals, Inc. (de) is expected to release its next quarterly earnings report in September.
Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 45.47% of Titan Pharmaceuticals, Inc. (de) shares while 3.52% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.46%.
BANK OF AMERICA CORP /DE/ holds the second largest percentage of outstanding shares.
